Related Experiment Videos
Neuropeptidergic inhibitory regulation of Met-enkephalin immunoreactive material release from rat spinal cord in
Abstract:
The release of Met-enkephalin immunoreactive material (ME-IR) from rat spinal slices was measured in vitro. This release increased about 4 fold in response to the addition of K+ ions. K+-evoked release of ME-IR was Ca++ dependent. Veratridine, a depolarizing agent, also stimulated the release of ME-IR. Veratridine-induced ME-IR release was completely prevented by tetrodotoxin (TTX), a Na+ channel blocker. Somatostatin (SRIF) inhibited both basal and K+-evoked release of ME-IR at 10(-7) M. Substance P had a similar effect although higher concentrations were needed. gamma-Aminobutyric acid (GABA) and neurotensin (NT) did not affect the basal release but slightly decreased K+-evoked release at 10(-5) M. Serotonin (5-HT) and noradrenaline (NA), did not affect ME-IR release. These results suggest that some of the neuropeptides present in the spinal cord, especially SP and SRIF, may be potent modulators of ME-IR release at the spinal level.
Insights
Spinal cord Met-enkephalin release is modulated by other neuropeptides. Somatostatin and Substance P significantly inhibit Met-enkephalin release, suggesting a role in pain regulation.
Area of Science:
- Neuroscience
- Neuropharmacology
- Spinal Cord Research
Background:
- Met-enkephalin (ME) is an endogenous opioid peptide involved in pain modulation.
- Understanding the regulation of ME release in the spinal cord is crucial for pain management strategies.
Purpose of the Study:
- To investigate the factors and substances that modulate the release of Met-enkephalin immunoreactive material (ME-IR) from rat spinal slices.
- To determine the role of specific neuropeptides in regulating ME-IR release at the spinal level.
Main Methods:
- Measurement of ME-IR release from rat spinal slices in vitro.
- Stimulation of release using potassium ions (K+) and veratridine.
- Assessment of the effects of calcium ions (Ca++), tetrodotoxin (TTX), somatostatin (SRIF), Substance P (SP), gamma-aminobutyric acid (GABA), neurotensin (NT), serotonin (5-HT), and noradrenaline (NA).
Main Results:
- K+-evoked ME-IR release was approximately 4-fold and dependent on Ca++.
- Veratridine-stimulated ME-IR release was blocked by TTX, indicating involvement of voltage-gated sodium channels.
- SRIF (10(-7) M) and SP (higher concentrations) inhibited both basal and K+-evoked ME-IR release.
- GABA and NT slightly decreased K+-evoked release, while 5-HT and NA had no effect.
Conclusions:
- The release of ME-IR from the spinal cord is regulated by neuronal depolarization and is calcium-dependent.
- Neuropeptides, particularly SRIF and SP, act as potent modulators of ME-IR release at the spinal level.
- These findings suggest a complex interplay of neurotransmitters and neuropeptides in spinal pain processing.